Gfinity, Kromek, N4 Pharma and Paul Hill on Housebuilders & the Markets
If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Gfinity, Kromek, N4 Pharma and Paul Hill on Housebuilders & the Markets
Paul Kent, Esports Director at Gfinity (GFIN) discusses what it means to be selected by Willow TV to deliver "The eCricket Challenge" in partnership with BetWay.
Gfinity is a world leading esports business. Created by gamers for the world's 2.2 billion gamers, Gfinity has a unique understanding of this fast-growing global community. It uses this expertise to provide both advisory services and to design, develop and deliver unparalleled experiences and winning strategies for game publishers, sports rights holders, commercial partners and media companies.
Arnab Basu, CEO Kromek Group (KMK) talks about their intention to commence production of Metran-based ventilators in response to COVID-19.
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
(Interview starts at 16 minutes 24 seconds)
Nigel Theobald, CEO N4 Pharma (N4P) discusses their project to demonstrate the ability of Nuvec® to be used as a delivery system by potential partners developing Covid-19 vaccines.
N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments using its unique silica nanoparticle delivery system called Nuvec®.
(Interview starts at 26 minutes 16 seconds)
Paul Hill, full time investor and equity analyst give his view on the market and what stocks he's been researching including:
Barratt Developments (BDEV)
Taylor Wimpey (TW.)
(Interview starts at 40 minutes 44 seconds)
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.